News|Videos|March 27, 2024

Why Aligning Laboratory Professionals and Infectious Disease Clinicians Can Deliver Favorable Diagnostics, Treatments

In today’s world of sophisticated, complex tests, an evolving relationship between laboratory professionals and clinicians can aid in providing a quicker diagnosis and help to achieve better patient outcomes.

In a traditional medical setting, when we think about the laboratory and diagnostic tests being conducted and we think about the clinic or hospital areas where patients are being cared for, they appear as 2 separate silos with laboratorians and clinicians possibly having very little to no interaction.

However, the development of more sophisticated assays such as rapid diagnostics and PCR testing, combined with concepts like time-to-treat and antimicrobial stewardship have led to the prospective need for the convergence of these 2 groups working together.

“It's such a different world now compared to even 10 years ago,” said Rodney E. Rohde, PhD, SV/SM/MB(ASCP)CM, FACSc, University Distinguished and Regents’ professor and chair for the Medical Laboratory Science Program in the College of Health Professions, Texas State University. “When you look at outcomes on data, you may need to know specific genotypes; you may need to have a full background on oncogenes; you might even have to have a pretty strong background in how to interpret statistical data—and I'm not talking about typical statistical data—I'm talking about the kind of high-level understanding of certain microarray gene expression analysis.”

Antimicrobial Stewardship and the Lab

Of course, the time-to-treat concept, which means getting patients optimal therapy in an efficient, timely manner remains critical, especially when seeing patients who are experiencing difficult-to-treat, gram-negative bacterial infections. Medical complications for these patients can include multidrug resistance combined with a treatment paradigm in which less effective testing is being conducted followed by prescribing practices that include broad-spectrum antibiotics, which do not always align with positive outcomes.

This is where laboratorians can play a key role. And some are advocating for laboratory professionals to be added to antimicrobial stewardship teams, especially as they can, “execute systemic interventions, facilitating appropriate identification of infections (and noninfections) through diagnostic stewardship.”1

Rohde talks about “being careful with how you work through testing.” He says there are situations where patients come into the emergency room and get a battery of tests that might not be warranted.

“Due to some confusion, or due to maybe not being certain, a dozen tests are ordered that are unnecessary…not only does that waste quality of health care, but it also wastes money. So, it gets to the bottom line of finance around the laboratory and the hospital overall.”

He says one strategy that can help alleviate this waste is the use of the diagnostic management team (DMT). These teams are designed to offer health care professionals assistance in selecting the appropriate diagnostic tests and interpreting results for individual patients. Rohde also says there are education programs that offer doctoral level medical lab scientist degrees, and should go a long way in bridging the knowledge gap.

“If you think about the laboratory and their role in providing that data that informs physicians and pharmacists, it just makes sense that we're on the same team. [This way, we] can discuss whether it's something as simple as what's the best test or assay to utilize to deal with a particular condition or disease,” Rohde said.

“We need to be certain, or as close to certain as we can get, that we're getting an accurate diagnosis, followed by an accurate susceptibility test, so that patients gets the right drug.”

Contagion will be introducing a podcast titled, From Pathogen to Diagnosis: Unraveling the Infectious Disease Mystery, and Rohde will be the host. Look for the podcast's launch in June.


Reference
1. Van Helden S, Ha D. Expanding the Antibiotic Stewardship Team Can Lead to Greater Adoption of Practices. Contagion. February-March 2024, Vol. 09, No. 1. https://www.contagionlive.com/view/expanding-the-antibiotic-stewardship-team-can-lead-to-greater-adoption-of-practices



Related to this article

Ceftriaxone Safety: Separating Signal From Risk
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.
Treatment of Latent Tuberculosis in a Trice
A retrospective study of 225 patients across Cook County Department of Health clinics found that the novel 1-month 1HP regimen (isoniazid plus rifapentine) for latent TB infection had a completion rate comparable to standard longer regimens and was well tolerated, suggesting it may be a viable shorter alternative.
Drawing Borders Around a Borderless Specialty
Editor in chief Jason Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS, discusses the proposed OMB rule restricting federal grants for international research collaboration, and how it threatens infectious disease medicine's inherently borderless surveillance networks, publication access, and knowledge-sharing systems.
Beyond Approval: Finding the Right Place for Emerging Gram-Negative Antibiotics
The expanding gram-negative antibiotic pipeline offers important new treatment options; however, FDA approval alone does not define a drug’s place in therapy. Clinicians must weigh the clinical problems that each agent solves, the strength of the evidence behind it, and what remains unknown before incorporating these therapies into routine practice.
A Review of Vibrio vulnificus: Clinical Presentation and Treatment
Vibrio species are bacteria that live in saltwater environments. When ingested orally or through contact with open wounds, some species can cause severe life-threatening infections, particularly in those with high-risk conditions, such as liver disease. Here is a review of Vibrio vulnificus and the recommended antibiotic treatment.